Amsterdam’s Phosphoenix raises €1.3 million to advance its neuroprosthetic system for people with profound blindness, with support from existing investors and ROM InWest.
Amount Raised
€1.3 Million
Round Type
Seed
AmsterdamBiotechnologyHealth CareInvestors
Description
Phosphoenix, a MedTech startup, has raised €1.3 million to advance its neuroprosthetic system for individuals with profound blindness. This funding will support the company's first-in-human clinical study and the development of its neurostimulation technology. The financing was supported by existing investors including TTT Medtech Fund and FIRST Fund, along with new investor ROM InWest. This marks a significant step towards clinical application and future Series A financing.
Who to call at Phosphoenix, and when
A new round usually means Phosphoenix is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Phosphoenix raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Phosphoenix, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Phosphoenix. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Phosphoenix raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Phosphoenix raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.